We found that S100B inhibition decreased the colonic levels of IL-1β, IL-18, IL-6, GMCSF, TNF-α, IL-17, IL-23, and IL-2, but not IL-33, during CDI (p < 0.05, Figures 3A–I). This evidence concerns the gene IL1B and clostridium difficile infection.